First Day of North American CF Conference Highlights Progress Made in CF Treatment and Roadmap for the Future
October 18, 2013
Nearly 4,000 cystic fibrosis researchers, physicians, caregivers and other medical professionals gathered in Salt Lake City yesterday for the 27th annual North American Cystic Fibrosis Conference (NACFC).
Cam McLoud, chair of the Cystic Fibrosis Foundation board of trustees, welcomed attendees to the first plenary and thanked them for their dedication to the Foundation’s mission. “Whether you’re conducting research in a lab or partnering with people with CF and their families in the clinic, you are changing lives and, together, we are making incredible progress.”
Following her opening remarks, Robert J. Beall, Ph.D., president and CEO of the Foundation, gave an overview of the latest advances in CF research, care and drug development, and outlined strategies for addressing challenges facing the CF community. Beall also showed a video of people with CF sharing their dreams for the future, and passionately addressed the audience: “I challenge all of you to continue to partner with us as we move forward to what will be our most exciting achievement — when all people with CF can live the life that we all dream of for our children and our childrens’ children.”
Scott Donaldson, M.D., of the University of North Carolina at Chapel Hill, capped off the first day with a presentation on the progress made in understanding and addressing the underlying cause of cystic fibrosis. For the first time ever, the plenary was broadcast live and a video of the presentation is available now.
Watch the My Dream video shown to plenary attendees:
To watch the third plenary, you must register online beforehand. Please note: the content of this session is intended for researchers and medical professionals and may not be appropriate for a general audience, especially children.
For updates from NACFC, follow us on Twitter.